# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 64


In regulation 87 (post authorisation requirements in relation to UK marketing authorisations with paediatric aspects and advanced therapy medicinal products), in the inserted regulation 78B (post authorisation requirements in relation to UK marketing authorisations for advanced therapy medicinal products)—
(a) in the heading to the regulation for “UK marketing authorisations” substitute “UKMA(GB)”;
(b) for “UK marketing authorisation” in each place it appears substitute “UKMA(GB)”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/64 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-64
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.